CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Pfreundschuh, Michael, Prof, Kuhnt, Evelyn, MSc, Trümper, Lorenz, Prof, Österborg, Anders, Prof, Trneny, Marek, Prof, Shepherd, Lois, MD, Gill, Devinder S, MD, Walewski, Jan, MD, Pettengell, Ruth, Prof, Jaeger, Ulrich, Prof, Zinzani, Pier-Luigi, MD, Shpilberg, Ofer, Prof, Kvaloy, Stein, Prof, de Nully Brown, Peter, MD, Stahel, Rolf, MD, Milpied, Noel, Prof, López-Guillermo, Armando, MD, Poeschel, Viola, MD, Grass, Sandra, MD, Loeffler, Markus, Prof, Murawski, Niels, MD
Published in The lancet oncology (01.10.2011)
Published in The lancet oncology (01.10.2011)
Get full text
Journal Article
Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case–control study
Grass, Sandra, MD, Preuss, Klaus-Dieter, PhD, Ahlgrimm, Manfred, Fadle, Natalie, Regitz, Evi, Pfoehler, Claudia, MD, Murawski, Niels, MD, Pfreundschuh, Michael, Prof
Published in The lancet oncology (01.10.2009)
Published in The lancet oncology (01.10.2009)
Get full text
Journal Article